INBX - Inhibrx Biosciences, Inc.
IEX Last Trade
15.16
0.240 1.583%
Share volume: 944
Last Updated: Fri 27 Dec 2024 08:30:38 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$14.92
0.24
1.61%
Summary score
26%
Profitability
25%
Dept financing
24%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-42.95%
Return on assets
-18.83%
Return on sales
-58861.89%
Return on invested capital
233.33%
Total debt ratio
93.29%
Debt ratio change over timeo
-0.58%
Current Ratio
7.15%
Quick Ratio
7.15%
Cash Position Ratio
6.81%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-186.48%
Return on assets
-21.49%
Return on sales
-60570%
Return on invested capital
191.41%
Total debt ratio
89.68%
Debt ratio change over timeo
-0.56%
Current Ratio
6.43%
Quick Ratio
6.43%
Cash Position Ratio
6.01%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-680.41%
Return on assets
-25.58%
Return on sales
0%
Return on invested capital
136.1%
Total debt ratio
95.99%
Debt ratio change over time
-0.55%
Current Ratio
3.82%
Quick Ratio
3.82%
Cash Position Ratio
3.51%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-133.92%
Return on assets
-108.84%
Return on sales
-24569.52%
Return on invested capital
3.54%
Total debt ratio
-58.35%
Debt ratio change over time
-0.58%
Current Ratio
2.22%
Quick Ratio
2.22%
Cash Position Ratio
2.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | INBX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -42.95% | 13.79% | 34.47% | 7.43% |
| Return on assets | -18.83% | 2.76% | 3.15% | 5.62% |
| Return on sales | -58861.89% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 233.33% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 93.29% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.58% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 49% | 24% | 7% |
| Current Ratio | 6.43% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.43% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.01% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 16% | 36% |
| Short-term ratios | INBX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -186.48% | 13.77% | 13.25% | 3.8% |
| Return on assets | -21.49% | 2.43% | 1.89% | 3.09% |
| Return on sales | -60570% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 191.41% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 89.68% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.56% | 46.38% | -72.08% | 1.51% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 6.43% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.43% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.01% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 51% |